Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Inventory Average (2016 - 2025)

Amicus Therapeutics filings provide 10 years of Inventory Average readings, the most recent being $203.4 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 73.73% to $203.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $203.4 million, a 73.73% increase, with the full-year FY2025 number at $173.8 million, up 94.76% from a year prior.
  • Inventory Average hit $203.4 million in Q4 2025 for Amicus Therapeutics, up from $166.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $203.4 million in Q4 2025 to a low of $17.1 million in Q3 2022.
  • Median Inventory Average over the past 5 years was $46.7 million (2023), compared with a mean of $66.7 million.
  • Biggest five-year swings in Inventory Average: decreased 26.01% in 2022 and later surged 217.17% in 2023.
  • Amicus Therapeutics' Inventory Average stood at $24.4 million in 2021, then decreased by 24.14% to $18.5 million in 2022, then surged by 214.47% to $58.3 million in 2023, then skyrocketed by 100.73% to $117.1 million in 2024, then surged by 73.73% to $203.4 million in 2025.
  • The last three reported values for Inventory Average were $203.4 million (Q4 2025), $166.4 million (Q3 2025), and $143.6 million (Q2 2025) per Business Quant data.